Skip to content

Pranic Healing as an Add-On Therapy for Managing Pain and Enhancing Well-being in Diabetic Neuropathy

Effects of Integrated Pranic Healing as Complementary Therapy on Pain management and Overall Wellbeing among patients with Peripheral Neuropathy in type 2 Diabetes: A Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075677
Enrollment
66
Registered
2024-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Conventional Treatment + Pranic Healing.: Conventional Treatment (Pregabalin 75 mg, Alpha-Lipoic Acid, Vitamin B complex + Complementary therapy of Pranic Healing (20 minutes session tw

Sponsors

World Pranic Healing Foundation India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants must provide written informed consent to participate in the study. 2. Male and female participants aged between 30 and 60 years. 3. Subjects with a clinical diagnosis of Type 2 diabetes 4. Peripheral neuropathy diagnosed using Semmes-Weinstein Monofilament (SWM) Test and Biothesiometry: 5. Having a history of peripheral neuropathy from onset to 9 years

Exclusion criteria

Exclusion criteria: 1. Subjects with other neurological conditions that affect hand function (e.g., stroke, multiple sclerosis, carpal tunnel syndrome, or someone with excessive alcoholic consumption (more than 21 units per week for men/ more than 15 units for women) will be excluded. 2. Subjects diagnosed with heart disease, renal failure with stage 3 and stage 4, severe hepatic disease, and diabetic foot ulcer. 3. Subjects with type 1 diabetes 4. Subjects with known vitamin B12 deficiency 5. Pregnant, and lactating women will be excluded. 6. Subjects with serious psychiatric disorders, or cognitive impairments that could affect their ability to follow the study protocol will be excluded. 7. Subjects who have had recent surgery or trauma affecting the extremities will be excluded. 8. Those who are participating in any other clinical trial or interventional study.

Design outcomes

Primary

MeasureTime frame
Relieve in pain symptoms as per Neuropathic Pain Symptom Inventory scoreTimepoint: 0, 5 weeks

Secondary

MeasureTime frame
reductions in scores of Depression, Anxiety, and Stress Scale - 21 Items (DASS-21) weeksTimepoint: 0, 5 weeks;Reductions in worry scores using Penn State Worry QuestionnaireTimepoint: 0, 5 weeks;Enhance in the score of Modified Diabetes Quality of Life scaleTimepoint: 0, 5 weeks;Improvement in Vibration Perception Threshold based on Biothesiometry testTimepoint: 0, 5 weeks;Improved sensory nerve conduction velocity based on mean score of Semmes-Weinstein Monofilament (SWM)Timepoint: 0, 5 weeks;Improved hand grip strength based on the mean score of the TTM Original DynamometerTimepoint: 0, 5 weeks;reduction in FBS and PPBSTimepoint: 0, 5 weeks;Temperature balance in both feetTimepoint: 0, 5 weeks;An open-ended questionnaire will be used for interviews with participants from the Pranic Healing group. The interviews will be recorded, transcribed, and then analyzed.Timepoint: 5 weeks

Countries

India

Contacts

Public ContactSrikanth Jois Nagaraja

Darlas Health Care

drbharishkumar@gmail.com09901502828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026